文献速递糖尿病肥胖与代谢综合征

PREDIMED试验血浆脂质组学与2型糖尿病风险

Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial.
PubMed 文献 · Diabetes Care · 2018-10-16

在PREDIMED试验中嵌套的病例队列研究,纳入250例新发2型糖尿病病例和692名基线无糖尿病参与者,重复测量207种血浆脂质代谢物。主成分分析构建的脂质因子显示,溶血磷脂、磷脂酰胆碱缩醛磷脂、鞘磷脂和胆固醇酯与T2D风险负相关,而三酰甘油、二酰甘油和磷脂酰乙醇胺与风险正相关。

要点

  • 基线溶血磷脂、PC缩醛磷脂、鞘磷脂和胆固醇酯与T2D风险负相关。
  • 基线三酰甘油、二酰甘油和磷脂酰乙醇胺与T2D风险正相关。
  • 含奇数链脂肪酸的TAG在调整总TAG后与T2D风险负相关。

核心结论

  • 两种不同脂质类组成的血浆脂质谱与高心血管风险人群的T2D风险相关,一种与较低风险相关,另一种与较高风险相关。

研究设计与样本

  • 在PREDIMED试验中嵌套的病例队列研究,中位随访3.8年,纳入250例新发T2D病例和692名基线无T2D参与者(639名非病例和53名重叠病例)。
  • 在基线和随访1年后重复测量207种血浆已知脂质代谢物,使用主成分分析构建脂质因子。

主要发现

  • 基线溶血磷脂酰胆碱和溶血磷脂酰乙醇胺(溶血磷脂[LPs])、磷脂酰胆碱缩醛磷脂(PC-PLs)、鞘磷脂(SMs)和胆固醇酯(CEs)与T2D风险负相关(多变量校正线性趋势P≤0.001)。
  • 基线三酰甘油(TAGs)、二酰甘油(DAGs)和磷脂酰乙醇胺(PEs)与T2D风险正相关(多变量校正线性趋势P<0.001)。
  • 这些脂质1年变化显示相似方向关联,但校正基线水平后不显著。
  • 含奇数链脂肪酸的TAGs在调整总TAGs后与T2D风险负相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Specific lipid molecular changes leading to type 2 diabetes (T2D) are largely unknown. We assessed lipidome factors associated with future occurrence of T2D in a population at high cardiovascular risk. RESEARCH DESIGN AND METHODS: We conducted a case-cohort study nested within the PREDIMED trial, with 250 incident T2D cases diagnosed during 3.8 years of median follow-up, and a random sample of 692 participants (639 noncases and 53 overlapping cases) without T2D at baseline. We repeatedly measured 207 plasma known lipid metabolites at baseline and after 1 year of follow-up. We built combined factors of lipid species using principal component analysis and assessed the association between these lipid factors (or their 1-year changes) and T2D incidence. RESULTS: Baseline lysophosphatidylcholines and lysophosphatidylethanolamines (lysophospholipids [LPs]), phosphatidylcholine-plasmalogens (PC-PLs), sphingomyelins (SMs), and cholesterol esters (CEs) were inversely associated with risk of T2D (multivariable-adjusted P for linear trend ≤0.001 for all). Baseline triacylglycerols (TAGs), diacylglycerols (DAGs), and phosphatidylethanolamines (PEs) were positively associated with T2D risk (multivariable-adjusted P for linear trend <0.001 for all). One-year changes in these lipids showed associations in similar directions but were not significant after adjustment for baseline levels. TAGs with odd-chain fatty acids showed inverse associations with T2D after adjusting for total TAGs. CONCLUSIONS: Two plasma lipid profiles made up of different lipid classes were found to be associated with T2D in participants at high cardiovascular risk. A profile including LPs, PC-PLs, SMs, and CEs was associated with lower T2D risk. Another profile composed of TAGs, DAGs, and PEs was associated with higher T2D risk.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Razquin C, Toledo E, Clish CB, et al. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial. Diabetes Care. 2018. PMID: 30327364. doi:10.2337/dc18-0840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。